Protalix Biotherapeutics Inc (NYSE-A:PLX) will participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025 on March 25-26.
The event includes a webcast presentation on March 25 at 12:00 p.m. EDT, followed by one-on-one meetings with investors on March 26.
Protalix develops recombinant therapeutic proteins using its ProCellEx platform.
The webcast can be accessed here, with a replay available for six months. More details and registration at iAccess Alpha.